Equine Veterinary Journal · 2021 · 15 citations · 43 references
PharmacyPharmacotherapyVeterinary PharmacologyEquine MedicineEquine ScienceGastrointestinal PharmacotherapyGastrointestinal PharmacologyPeptic Ulcer PharmacotherapyPreventive Veterinary MedicineEquine Gastric Ulcer SyndromeEquine PharmacologyGastric PathologyGastric Ulcer DiseaseNonsteroidal Anti-inflammatory Drug ManagementNonsteroidal Anti-inflammatory Drug PharmacologyNonsteroidal Anti-inflammatory Drug-induced UlcersNsaid-induced Ulcer Prevention
BACKGROUND: Equine gastric ulcer syndrome (EGUS) is a common and significant cause of morbidity in horses, with a range of clinical signs, including inappetence, colic and poor performance. Hospitalised horses are exposed to factors that may induce EGUS, including fasting and nonsteroidal anti-inflammatory drug (NSAID) administration, and may be at risk for development of squamous (ESGD) and glandular gastric disease (EGGD). Prophylactic anti-ulcer medication is often prescribed for these patients, but drug selection is complicated by different aetiology and response to treatment of ESGD and EGGD. OBJECTIVES: To establish the efficacy of sucralfate or omeprazole used prophylactically in horses exposed to a combined feed-fast and NSAID administration EGUS induction protocol. We hypothesised that these drugs would be equally effective for prevention of gastric lesions in the experimental cohort. STUDY DESIGN: Randomised crossover experimental design. METHODS: Horses (n = 14) received either omeprazole (1 mg/kg PO q24h) or sucralfate (20 mg/kg PO q8h) while undergoing the feed-fast/NSAID protocol, allowed an 8-week washout period, and then administered the alternate treatment. Serial gastroscopy, ultrasound and haematology documented treatment effects. RESULTS: ESGD and EGGD score increased over time under both treatments. There was a significant effect of treatment on EGGD scores (P < .001), with post-treatment EGGD scores higher for horses receiving sucralfate (median 3; IQR 2.25,3) than omeprazole (1; 1,1). The effect of treatment on ESGD scores just achieved significance (P = .05), with post-treatment ESGD scores higher for sucralfate (4; 3,4) than omeprazole (2; 2,3). MAIN LIMITATIONS: This study was performed in healthy horses, and response to treatment may differ in horses with clinical illness. Additional investigation in a larger population may be required to detect significant differences in other clinical parameters. CONCLUSIONS: Omeprazole was superior to sucralfate for mitigating gastric lesion severity in healthy horses exposed to a feed-fast/NSAID model.
43
R: A Language and Environment for Statistical Computing
R Core Team · 2000 · 353K citations · Full text
Natural Sciences, Computer Science, Statistical Computing +10
B. W. Sykes, Michael Hewetson, Richard Hepburn et al. · Journal of Veterinary Internal Medicine · 2015 · 322 citations · Full text
Veterinary Medicine, Veterinary Clinical Sciences, Veterinary Internal Medicine +16
Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses
Charles G. MacAllister, Sheryl J. Morgan, Agatha Borne et al. · Journal of the American Veterinary Medical Association · 1993 · 321 citations · Full text
Veterinary Medicine, Toxicology, Veterinary Pharmacology +12